OBJECTIVES: To assess whether vessel morphology depicted by three-dimensional (3D) power Doppler ultrasound improves discrimination between benignity and malignancy if used as a second-stage test in adnexal masses that are difficult to classify. METHODS: This was a prospective observational international multicenter diagnostic accuracy study. Consecutive patients with an adnexal mass underwent standardized transvaginal two-dimensional (2D) grayscale and color or power Doppler and 3D power Doppler ultrasound examination by an experienced examiner, and those with a 'difficult' tumor were included in the current analysis. A difficult tumor was defined as one in which the International Ovarian Tumor Analysis (IOTA) logistic regression model-1 (LR-1) yielded an ambiguous result (risk of malignancy, 8.3% to 25.5%), or as one in which the ultrasound examiner was uncertain regarding classification as benign or malignant when using subjective assessment. Even when the ultrasound examiner was uncertain, he/she was obliged to classify the tumor as most probably benign or most probably malignant. For each difficult tumor, one researcher created a 360° rotating 3D power Doppler image of the vessel tree in the whole tumor and another of the vessel tree in a 5-cm3 spherical volume selected from the most vascularized part of the tumor. Two other researchers, blinded to the patient's history, 2D ultrasound findings and histological diagnosis, independently described the vessel tree using predetermined vessel features. Their agreed classification was used. The reference standard was the histological diagnosis of the mass. The sensitivity of each test for discriminating between benign and malignant difficult tumors was plotted against 1 - specificity on a receiver-operating-characteristics diagram, and the test with the point furthest from the reference line was considered to have the best diagnostic ability. RESULTS: Of 2403 women with an adnexal mass, 376 (16%) had a difficult mass. Ultrasound volumes were available for 138 of these cases. In 79/138 masses, the ultrasound examiner was uncertain about the diagnosis based on subjective assessment, in 87/138, IOTA LR-1 yielded an ambiguous result and, in 28/138, both methods gave an uncertain result. Of the masses, 38/138 (28%) were malignant. Among tumors that were difficult to classify as benign or malignant by subjective assessment, the vessel feature 'densely packed vessels' had the best discriminative ability (sensitivity 67% (18/27), specificity 83% (43/52)) and was slightly superior to subjective assessment (sensitivity 74% (20/27), specificity 60% (31/52)). In tumors in which IOTA LR-1 yielded an ambiguous result, subjective assessment (sensitivity 82% (14/17), specificity 79% (55/70)) was superior to the best vascular feature, i.e. changes in the diameter of vessels in the whole tumor volume (sensitivity 71% (12/17), specificity 69% (48/70)). CONCLUSION: Vessel morphology depicted by 3D power Doppler ultrasound may slightly improve discrimination between benign and malignant adnexal tumors that are difficult to classify by subjective ultrasound assessment. For tumors in which the IOTA LR-1 model yields an ambiguous result, subjective assessment is superior to vessel morphology as a second-stage test. © 2020 The Authors. Ultrasound in Obstetrics & Gynecology published by John Wiley & Sons Ltd on behalf of International Society of Ultrasound in Obstetrics and Gynecology.

1st Department of Gynecological Oncology and Gynecology Medical University of Lublin Lublin Poland

Department of Clinical Science and Education Karolinska Institute Södersjukhuset Stockholm Sweden

Department of Clinical Sciences Malmö Lund University Malmö Sweden

Department of Development and Regeneration KU Leuven Leuven Belgium

Department of Gynecological Oncology Catholic University of the Sacred Heart Rome Italy

Department of Obstetrics and Gynecology 1st Faculty of Medicine Charles University and 1st Faculty of Medicine Prague Czech Republic

Department of Obstetrics and Gynecology and Leuven Cancer Institute University Hospitals Leuven Leuven Belgium

Department of Obstetrics and Gynecology Ikazia Hospital Rotterdam Rotterdam The Netherlands

Department of Obstetrics and Gynecology San Gerardo Hospital University of Milan Bicocca Monza Italy

Department of Obstetrics and Gynecology Skåne University Hospital Malmö Sweden

Department of Obstetrics and Gynecology University of Cagliari Policlinico Universitario Duilio Casula Monserrato Cagliari Italy

Department of Obstetrics and Gynecology Ziekenhuis Oost Limburg Genk Belgium

Department of Obstetrics Gynecology and Reproduction Hospital Universitari Dexeus Barcelona Spain

Gynecology and Reproductive Medicine Unit S Orsola Malpighi Hospital University of Bologna Bologna Italy

Jules Bordet Institute Université Libre de Bruxelles Brussels Belgium

Preventive Gynecology Unit Division of Gynecology European Institute of Oncology Milan Italy

Ultrasound Obstet Gynecol. 2021 Jun;57(6):1016. doi: 10.1002/uog.23661. PubMed

Ultrasound Obstet Gynecol. 2021 Jun;57(6):1015-1016. doi: 10.1002/uog.23659. PubMed

Zobrazit více v PubMed

Valentin L, Hagen B, Tingulstad S, Eik‐Nes S. Comparison of ‘pattern recognition’ and logistic regression models for discrimination between benign and malignant pelvic masses: a prospective cross validation. Ultrasound Obstet Gynecol 2001; 18: 357–365. PubMed

Timmerman D. The use of mathematical models to evaluate pelvic masses; can they beat an expert operator? Best Pract Res Clin Obstet Gynaecol 2004; 18: 91–104. PubMed

Valentin L, Ameye L, Jurkovic D, Metzger U, Lécuru F, Van Huffel S, Timmerman D. Which extrauterine pelvic masses are difficult to correctly classify as benign or malignant on the basis of ultrasound findings and is there a way of making a correct diagnosis? Ultrasound Obstet Gynecol 2006; 27: 438–444. PubMed

Valentin L, Ameye L, Savelli L, Fruscio R, Leone FP, Czekierdowski A, Lissoni AA, Fischerova D, Guerriero S, Van Holsbeke C, Van Huffel S, Timmerman D. Adnexal masses difficult to classify as benign or malignant using subjective assessment of gray‐scale and Doppler ultrasound findings: logistic regression models do not help. Ultrasound Obstet Gynecol 2011; 38: 456–465. PubMed

Valentin L, Ameye L, Savelli L, Fruscio R, Leone FP, Czekierdowski A, Lissoni AA, Fischerova D, Guerriero S, Van Holsbeke C, Van Huffel S, Timmerman D. Unilocular adnexal cysts with papillary projections but no other solid components: is there a diagnostic method that can classify them reliably as benign or malignant before surgery? Ultrasound Obstet Gynecol 2013; 41: 570–581. PubMed

Timmerman D, Testa AC, Bourne T, Ferrazzi E, Ameye L, Konstantinovic ML, Van Calster B, Collins WP, Vergote I, Van Huffel S, Valentin L; International Ovarian Tumor Analysis Group . Logistic regression model to distinguish between the benign and malignant adnexal mass before surgery: a multicenter study by the International Ovarian Tumor Analysis Group. J Clin Oncol 2005; 23: 8794–8801. PubMed

Timmerman D, Van Calster B, Testa AC, Guerriero S, Fischerova D, Lissoni AA, Van Holsbeke C, Fruscio R, Czekierdowski A, Jurkovic D, Savelli L, Vergote I, Bourne T, Van Huffel S, Valentin L. Ovarian cancer prediction in adnexal masses using ultrasound‐based logistic regression models: a temporal and external validation study by the IOTA group. Ultrasound Obstet Gynecol 2010; 36: 226–234. PubMed

Daemen A, Valentin L, Fruscio R, Van Holsbeke C, Melis GB, Guerriero S, Czekierdowski A, Jurkovic D, Ombelet W, Rossi A, Vergote I, Bourne T, De Moor B, Timmerman D. Improving the preoperative classification of adnexal masses as benign or malignant by second‐stage tests. Ultrasound Obstet Gynecol 2011; 37: 100–106. PubMed

Van Calster B, Timmerman D, Bourne T, Testa AC, Van Holsbeke C, Domali E, Jurkovic D, Neven P, Van Huffel S, Valentin L. Discrimination between benign and malignant adnexal masses by specialist ultrasound examination versus serum CA125. J Natl Cancer Inst 2007; 99: 1706–1714. PubMed

Valentin L, Jurkovic D, Van Calster B, Testa A, Van Holsbeke C, Bourne T, Vergote I, Van Huffel S, Timmerman D. Adding a single CA125 measurement to ultrasound imaging performed by an experienced examiner does not improve preoperative discrimination between benign and malignant adnexal masses. Ultrasound Obstet Gynecol 2009; 34: 345–354. PubMed

Valentin L. Imaging in gynecology. Best Pract Res Clin Obstet Gynaecol 2006; 20: 881–906. PubMed

Kaijser J, Vandecaveye V, Deroose CM, Rockall A, Thomassin‐Naggara I, Bourne T, Timmerman D. Imaging techniques for the pre‐surgical diagnosis of adnexal tumours. Best Pract Res Clin Obstet Gynaecol 2014; 28: 683–695. PubMed

Pereira PN, Sarian LO, Yoshida A, Araújo KG, Silva ACB, de Oliveira Barros RH, Jales RM, Derchain S. Improving the performance of IOTA simple rules: sonographic assessment of adnexal masses with resource‐effective use of a magnetic resonance scoring (ADNEX MR scoring system). Abdom Radiol (NY) 2020; 45: 3218–3229. PubMed

Sladkevicius P, Jokubkiene L, Valentin L. Contribution of morphological assessment of the vessel tree by three‐dimensional ultrasound to a correct diagnosis of malignancy in ovarian masses. Ultrasound Obstet Gynecol 2007; 30: 874–882. PubMed

Testa A, Kaijser J, Wynants L, Fischerova D, Van Holsbeke C, Franchi D, Savelli L, Epstein E, Czekierdowski A, Guerriero S, Fruscio R, Leone FP, Vergote I, Bourne T, Valentin L, Van Calster B, Timmerman D. Strategies to diagnose ovarian cancer: new evidence from phase 3 of the multicentre international IOTA study. Br J Cancer 2014; 111: 680–688. PubMed PMC

Timmerman D , Valentin L, Bourne TH, Collins WP, Verrelst H, Vergote I; International Ovarian Tumor Analysis (IOTA) Group . Terms, definitions and measurements to describe the sonographic features of adnexal tumors: a consensus opinion from the International Ovarian Tumor Analysis (IOTA) Group. Ultrasound Obstet Gynecol 2000; 16: 500–505. PubMed

Heintz APM, Odicino F, Maisonneuve P, Beller U, Benedet JL, Creasman WT, Ngan HYS, Pecorelli S. Carcinoma of the Ovary, 25th Annual Report on the Results of Treatment in Gynecological Cancer. Int J Gynecol Obstet 2003; 83 (Suppl 1): S135–S166.

Cohen J. A coefficient of agreement for nominal scales. Educ Psychol Meas 1960; 20: 37–46.

Brennan P, Silman A. Statistical methods for assessing observer variability in clinical measures. BMJ 1992; 304: 1491–1494. PubMed PMC

Westfall PH, Wolfinger RD. Multiple tests with discrete distributions. Am Stat 1997; 51: 3

Cohen JF, Korevaar DA, Altman DG, Bruns DE, Gatsonis CA, Hooft L, Irwig L, Levine D, Reitsma JB, de Vet HC, Bossuyt PM. STARD 2015 guidelines for reporting diagnostic accuracy studies: explanation and elaboration. BMJ Open 2016; 6: e012799. PubMed PMC

Jokubkiene L, Sladkevicius P, Valentin L. Does three‐dimensional power Doppler ultrasound help in discrimination between benign and malignant ovarian masses? Ultrasound Obstet Gynecol 2007; 29: 215–225. PubMed

Froyman W, Landolfo C, De Cock B, Sladkevicius P, Testa AC, Van Holsbeke C, Domali E, Fruscio R, Epstein E, Dos Santos Bernardo MJ, Franchi D, Kudla MJ, Chiappa V, Alcazar JL, FPG Leone, Buonomo F, Hochberg L, Coccia ME, Guerriero S, Deo N, Jokubkiene L, Kaijser J, Coosemans A, Vergote I, Verbakel JY, Bourne T, van Calster B, Valentin L, Timmerman D. Risk of complications in patients with conservatively managed ovarian tumours (IOTA5): a 2‐year interim analysis of a multicentre, prospective, cohort study. Lancet Oncol 2019; 20: 448–458. PubMed

4D Doppler Ultrasound in High Grade Serous Ovarian Cancer Vascularity Evaluation-Preliminary Study